NCT00538642View on ClinicalTrials.gov

Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

April 30, 2011

Study Completion Date

November 30, 2011

Conditions
SchizophreniaSchizoaffective DisorderBipolar Disorder
Interventions
DRUG

ziprasidone

Patients assigned to ziprasidone arm are cross-titrated from current antipsychotic

Trial Locations (1)

78229

The University of Texas Health Science Center At San Antonio, San Antonio

All Listed Sponsors
lead

The University of Texas Health Science Center at San Antonio

OTHER

NCT00538642 - Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone | Biotech Hunter | Biotech Hunter